Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF
about
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsmiRNA expression and function in thyroid carcinomas: a comparative and critical analysis and a model for other cancersAnaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer.Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models.Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma.Characterization of human follicular thyroid cancer cell lines in preclinical mouse modelsExpression of angiogenic switch, cachexia and inflammation factors at the crossroad in undifferentiated thyroid carcinoma with BRAF(V600E).Galectin-1 is a diagnostic marker involved in thyroid cancer progression.A versatile orthotopic nude mouse model for study of esophageal squamous cell carcinoma.Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer.Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model.
P2860
Q27027491-199F7509-EF17-4276-8C99-2D66BC11743EQ28078451-39EE7232-792F-4A06-9163-4D22DF1C27FBQ33914771-4E47B79D-BD2C-4A6E-82FC-2EB42A93F6B7Q34100838-66F78097-58E4-4475-80E1-D406CF868A0EQ35554680-57784E32-C4A8-4CF3-8DEF-13930E8D64B3Q36171837-E9047E11-DB98-431F-ADFD-5107EAB68DCEQ36618887-66D55D04-D6C1-41E8-8B72-9B038577952DQ36905783-A35BA7F2-38B4-40B8-B37F-FC314CA055E7Q37212935-433089DD-F0DD-4DCD-9788-469B2E005566Q38851509-21E24355-D9C3-46B0-B825-7E5BCDB59656Q41470048-3C52CF1D-51A9-460E-B28B-5851E64AA99FQ42180656-D70AC95F-6AD6-4707-A769-73393DD788D5Q49475238-847DC633-56B4-4B26-AA42-13ADFF9C9FF6Q50954816-0C4A690C-4CBD-412E-9343-ACEF743BCA42
P2860
Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@ast
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@en
type
label
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@ast
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@en
prefLabel
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@ast
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@en
P2860
P356
P1433
P1476
Orthotopic mouse models for th ...... BRAF(V600E) or wild-type BRAF
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.544
P407
P577
2013-12-23T00:00:00Z
P6179
1049447314